Taylor Fritz | Eight Sleep Names Him Athlete Ambassador and Investor to Power the Next Generation of Tennis Legends

Taylor Fritz

Eight Sleep, the world’s first sleep fitness company, today announces that Taylor Fritz, the highest-ranked American male Tennis player, joins the company as an Athlete Ambassador and Investor. This partnership also marks Eight Sleep’s official entry into tennis, a sport that rewards consistency through a grueling year-round training season with multi-week tournaments, four annual Grand Slams and continuous travel around the world. As Fritz and other young talent challenge the long-term reign of tennis legends, every detail matters – including getting quality sleep – when it comes to finding a performance edge and winning matches.

Impressive Lineup of Athletes

Taylor Fritz joins an impressive lineup of more than 300 professional athletes from various sports disciplines, including some of the world’s most decorated tennis players, who are already using Eight Sleep as an instrumental tool to uplevel their recovery and performance, including Aaron Judge (Baseball), Brock Purdy (NFL), Jimmy Butler (NBA), Lewis Hamilton (F1) and the EF Cycling Team.

Sleep is quickly becoming the next big secret that today’s highest performers are seeking to amplify to better their fitness and health. Fritz began using Eight Sleep’s Pod in early 2023 as a way to optimize sleep and recovery and enhance his on-court performance. He quickly realized he couldn’t live without Eight Sleep’s innovative sleep technology, which is clinically proven to improve sleep quality up to 32% and increase deep sleep and heart rate variability, key factors in recovery.

Taylor Fritz

“I fell in love with how the Pod made me feel since the first time I tried Eight Sleep, it helped my body recover much faster than I have ever experienced during a training block. Not only did it help my body feel more alert and ready to perform, but it also improved my mental game, keeping me more focused and sharp during long training sessions on the court and at the gym. It’s been an incredible tool for my game this past year.”

As an ambassador and investor, Taylor Fritz aims to further establish the Pod as a key tool for all up-and-coming tennis players to use as they train. He will now be equipped with a Pod anywhere he travels, ensuring he reaps the benefits of sleep optimization as he attends Grand Slams and tournaments around the world, and as he sets his eyes on joining Team USA in Paris this summer. Fritz will also be creating content with Eight Sleep to spread awareness of the importance of sleep fitness and healthy sleep habits for young athletes.

The Eight Sleep Pod

The first innovative sleep technology to combine thermo-regulation, biometric tracking, smart home integrations, and sleep coaching to deliver a total solution for enhanced rest and recovery.

The Pod is powered by Autopilot, a collection of proprietary algorithms developed by Eight Sleep to create an individual blueprint of each sleeper: as a user’s body temperature changes overnight through the various stages of sleep, Autopilot heats and cools the Pod to match the body’s natural rhythm, keeping users in deep sleep for longer and maximizing time in each sleep stage for optimized sleep.

Launched in February 2019, the Eight Sleep Pod has been named one of TIME’s Best Inventions of the Year and one of Fast Company’s Most Innovative Companies. With close to 1 billion hours of sleep data to guide their research and product development, the Eight Sleep Pod is doing what no other company is doing to redefine the entire experience of sleep for the world’s top performers.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.